Skip to main content

New owner for Chemtrix

The AGI Group has acquired Chemtrix, a Netherlands-based maker of flow reactors for industry and academia. It said that this “will bring flow chemistry scale-up capabilities into the AGI Group, supporting both pilot and manufacturing solutions”. Terms were not disclosed.

Axplora, Flamma invest in flow chemistry

CDMOs Axplora and Flamma have both made announcements about investments in flow chemistry, with the former completing the installation of a new cGMP pilot unit at Leverkusen, Germany, and the latter investing about $2 million in flow, starting with the installation of a new suite of equipment from Microinnova at Chignolo D’Isola, Italy.

Curia, Corning join forces

CDMO Curia is to collaborate with Corning’s Advanced-Flow Reactor (AFR) team to expand and accelerate continuous flow development and manufacturing for the chemical and biopharmaceutical industries.  This includes installing Corning’s G1 production system (pictured), designed for the continuous industrial production of APIs at Curia’s Albany facility.

Snapdragon finds alternative buyer in Cambrex

CDMO Cambrex has agreed to buy Snapdragon Chemistry, a US-based provider of chemical process development services to the biopharma sector. Terms were not disclosed. This came two months after regulatory approval was denied to Asymchem Laboratories’ acquisition of Snapdragon.

Singapore site for WuXi AppTec

WuXi AppTec has announced a plan to build a new R&D and manufacturing site in Singapore at a cost of up to $1.4 billion. It will be created in stages over the next ten years, depending on the company’s business needs.

The company added that the site will serve “a critical role in its global network across Asia, Europe and North America”. It ill include “laboratories and facilities that provide a broad portfolio of R&D and manufacturing services” for the pharmaceutical industry.

Multi-track investment for CordenPharma

CDMO CordenPharma is planning to invest heavily in all its platforms in terms of both capacities and capabilities, according to Dr Stephen Houldsworth, global head of platform management and marketing, who spoke with SCM at CPhI Worldwide in Milan.

Flow chemistry first for Seqens

Seqens will produce the first volumes of an aromatic diamine monomer by means of flow chemistry in its dedicated workshop at SeqensLab in Porcheville, France (pictured), by the end of 2021. This follows a successful first pilot trial in 2020.

Subscribe to flow chemistry